| # | Title | Journal | Year | Citations |
|---|
| 1 | Role of tissue-factor bearing extracellular vesicles released from ovarian cancer cells in platelet aggregation in vitro and venous thrombosis in mice | Thrombosis Update | 2021 | 15 |
| 2 | Acute limb ischemia in a COVID-19 patient | Thrombosis Update | 2021 | 13 |
| 3 | Thrombosis of pulmonary vasculature despite anticoagulation and thrombolysis: The findings from seven autopsies | Thrombosis Update | 2020 | 11 |
| 4 | Clinical characteristics and outcomes of venous thromboembolism in patients hospitalized for COVID-19: Systematic review and meta-analysis | Thrombosis Update | 2021 | 11 |
| 5 | Risk assessment models of cancer-associated thrombosis - Potentials and perspectives | Thrombosis Update | 2021 | 11 |
| 6 | Antiplatelet therapy in patients with Covid-19: A retrospective observational study | Thrombosis Update | 2021 | 10 |
| 7 | Thrombosis: Current knowledge based on metabolomics by nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) | Thrombosis Update | 2020 | 8 |
| 8 | Fibrinolysis shut down in COVID-19 patients: Report on two severe cases with potential diagnostic and clinical relevance | Thrombosis Update | 2020 | 8 |
| 9 | Systematic testing for venous thromboembolism in hospitalized patients with COVID-19 and raised D-dimer levels | Thrombosis Update | 2021 | 8 |
| 10 | Thrombosis in myeloproliferative neoplasms: A clinical and pathophysiological perspective | Thrombosis Update | 2021 | 8 |
| 11 | COVID-19, thrombosis and pregnancy | Thrombosis Update | 2021 | 8 |
| 12 | The role of the fibrinolytic system in female reproductive disorders and depression | Thrombosis Update | 2020 | 6 |
| 13 | Mortality, critical illness, and mechanical ventilation among hospitalized patients with COVID-19 on therapeutic anticoagulants | Thrombosis Update | 2021 | 6 |
| 14 | Direct oral anticoagulant blood level monitoring in daily practice | Thrombosis Update | 2021 | 6 |
| 15 | No changes of parameters nor coagulation activation in healthy subjects vaccinated for SARS-Cov-2 | Thrombosis Update | 2021 | 6 |
| 16 | The role of the PERT team in 2021 | Thrombosis Update | 2022 | 6 |
| 17 | Intervention in COVID-19 linked hypercoaguable states characterized by circuit thrombosis utilizing a direct thrombin inhibitor | Thrombosis Update | 2020 | 5 |
| 18 | Updates on thrombotic thrombocytopenic purpura: Recent developments in pathogenesis, treatment and survivorship | Thrombosis Update | 2021 | 5 |
| 19 | Risk assessment for recurrent venous thromboembolism in patients with cancer | Thrombosis Update | 2021 | 5 |
| 20 | Risk factors for Venous Thromboembolism and clinical outcomes in adults with sickle cell disease | Thrombosis Update | 2022 | 5 |
| 21 | Surviving and thriving in thrombosis research during a global pandemic: Experiences of a vascular scientist diagnosed with COVID-19 | Thrombosis Update | 2021 | 4 |
| 22 | Incidence, risk factors and clinical outcome of venous thromboembolism in non-small cell lung cancer patients receiving immune checkpoint inhibition | Thrombosis Update | 2021 | 4 |
| 23 | Pre-stroke factors (morbitities, diet, medication, demograhics) that affect the severity of a stroke | Thrombosis Update | 2021 | 4 |
| 24 | Disseminated intravascular coagulation in pregnancy: New insights | Thrombosis Update | 2022 | 4 |
| 25 | Vaccine-induced thrombosis and thrombocytopenia (VITT) in Ireland: A review of cases and current practices | Thrombosis Update | 2021 | 4 |
| 26 | The thrombotic spectrum of B-thalassemia | Thrombosis Update | 2022 | 4 |
| 27 | VTE epidemiology and challenges for VTE prevention at the population level | Thrombosis Update | 2023 | 4 |
| 28 | Monocytes could be a bridge from inflammation to thrombosis on COVID-19 injury: A case report | Thrombosis Update | 2020 | 3 |
| 29 | Challenges in classification of novel CFH variants in patients with atypical hemolytic uremic syndrome | Thrombosis Update | 2020 | 3 |
| 30 | Negatively charged phospholipids stimulate factor XI activation by thrombin | Thrombosis Update | 2021 | 3 |
| 31 | Update on extended prophylaxis for venous thromboembolism following surgery for gynaecological cancers | Thrombosis Update | 2021 | 3 |
| 32 | The prognostic value of ECG-derived ventricular gradient in early adverse events in acute pulmonary embolism patients | Thrombosis Update | 2021 | 3 |
| 33 | Novel biomarkers to detect occult cancer in patients with unprovoked venous thromboembolism: Rationale and design of the PLATO-VTE study | Thrombosis Update | 2021 | 3 |
| 34 | Real-world data of thrombotic microangiopathy management: The key role of ADAMTS13 activity and complement testing | Thrombosis Update | 2021 | 3 |
| 35 | Global coagulation assays to measure in vitro fibrinolysis | Thrombosis Update | 2021 | 3 |
| 36 | “Portal vein thrombosis occurring after the first dose of mRNA SARS-CoV-2 vaccine in a patient with antiphospholipid syndrome” | Thrombosis Update | 2021 | 3 |
| 37 | Update on laboratory testing and hemostasis assessment in patients receiving direct oral anticoagulants (DOACs) | Thrombosis Update | 2021 | 3 |
| 38 | Predictors of thrombosis in patients treated with bevacizumab | Thrombosis Update | 2022 | 3 |
| 39 | Advancing anticoagulation stewardship: A call to action for stewardship from the US-based anticoagulation forum | Thrombosis Update | 2022 | 3 |
| 40 | Venous thrombotic events in severe and critically COVID-19 patients despite high dose prophylactic low-molecular-weight heparin | Thrombosis Update | 2020 | 2 |
| 41 | The evaluation of a scoring system for diagnosing atypical hemolytic uremic syndrome | Thrombosis Update | 2020 | 2 |
| 42 | Development of a brief screening instrument for emotional distress associated with thromboembolism | Thrombosis Update | 2020 | 2 |
| 43 | Vitamin B12 malabsorption and pseudo- thrombotic microangiopathy in an adolescent | Thrombosis Update | 2021 | 2 |
| 44 | Coagulation factor V inhibitors, a review of the case report literature | Thrombosis Update | 2021 | 2 |
| 45 | Don't forget arterial thrombosis in patients with COVID-19: A case series | Thrombosis Update | 2021 | 2 |
| 46 | A case report of mesenteric and portal vein thrombosis in a patient with Fusobacterium nucleatum bacteremia | Thrombosis Update | 2021 | 2 |
| 47 | Biomarkers of thromboinflammation correlate to COVID-19 infection and admission status in emergency department patients | Thrombosis Update | 2021 | 2 |
| 48 | Venous thromboembolism risk, prophylaxis and management in cancer patients with COVID-19: An unmet medical need | Thrombosis Update | 2022 | 2 |
| 49 | Thromboembolic complications during and after hospitalization for COVID-19: Incidence, risk factors and thromboprophylaxis | Thrombosis Update | 2022 | 2 |
| 50 | Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS) | Thrombosis Update | 2022 | 2 |
